{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:34:28Z","timestamp":1778038468890,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005623","name":"University of Tokushima","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijbiomac.2021.01.201","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:59:05Z","timestamp":1612292345000},"page":"494-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX\/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft model"],"prefix":"10.1016","volume":"174","author":[{"given":"Shunsuke","family":"Akagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokuo","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatomo","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0005","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0010","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","article-title":"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer","volume":"23","author":"Jones","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0015","first-page":"2667","article-title":"A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study)","volume":"27","author":"Kodera","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from Taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0025","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijpharm.2017.05.016","article-title":"Paclitaxel: what has been done and the challenges remain ahead","volume":"526","author":"Bernabeu","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0035","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/annonc\/mdn661","article-title":"Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane\u00ae) in combination with gemcitabine in patients with metastatic breast cancer (N0531)","volume":"20","author":"Roy","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0045","doi-asserted-by":"crossref","unstructured":"M. Fukuchi, E. Mochiki, T. Ishiguro, T. Ogura, J. Sobajima, Y. Kumagai, K. Ishibashi, H. Ishida, Efficacy of nab-paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer, Anticancer Res. 36 (2016) 6699\u20136703. doi:10.21873\/anticanres.11281.","DOI":"10.21873\/anticanres.11281"},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1018431705579","article-title":"Cellulose: the structure slowly unravels","volume":"4","author":"O\u2019Sullvian","year":"1997","journal-title":"Cellulose."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-016-0230-9","article-title":"A critical review of the current knowledge regarding the biological impact of nanocellulose","volume":"14","author":"Endes","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.carbpol.2016.12.050","article-title":"Preparation, properties and applications of nanocellulosic materials","volume":"163","author":"Mondal","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0065","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2147\/IJN.S124318","article-title":"Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery","volume":"12","author":"Bhandari","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/btpr.2598","article-title":"Preparation of an injectable doxorubicin surface modified cellulose nanofiber gel and evaluation of its anti-tumor and anti-metastasis activity in melanoma","volume":"34","author":"Alizadeh","year":"2018","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.msec.2016.12.048","article-title":"Regenerated cellulose micro-nano fiber matrices for transdermal drug release","volume":"74","author":"Liu","year":"2017","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0080","doi-asserted-by":"crossref","unstructured":"M. Iguchi;, S. Yamanaka;, A. Budhiono;, Bacterial cellulose - a masterpiece of nature's arts, J. Mater. Sci. 35 (2000) 261\u2013270. doi:10.1023\/A.","DOI":"10.1023\/A:1004775229149"},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0085","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s10570-013-0050-0","article-title":"One-step production of nanofibrillated bacterial cellulose (NFBC) from waste glycerol using Gluconacetobacter intermedius NEDO-01","volume":"20","author":"Kose","year":"2013","journal-title":"Cellulose."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/acs.biomac.9b01328","article-title":"Detailed structural analyses of nanofibrillated bacterial cellulose and its application as binder material for a display device","volume":"21","author":"Tajima","year":"2020","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0095","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1021\/acs.biomac.7b01100","article-title":"One-step production of amphiphilic nanofibrillated cellulose using a cellulose-producing bacterium","volume":"18","author":"Tajima","year":"2017","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2017.09.064","article-title":"Cellulose nanofibers as excipient for the delivery of poorly soluble drugs","volume":"533","author":"L\u00f6bmann","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejso.2006.03.008","article-title":"Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination","volume":"32","author":"de Bree","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ogx.0000206353.22975.c5","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer: commentary","volume":"61","author":"Jones","year":"2006","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0115","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1002\/cam4.2598","article-title":"A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model","volume":"8","author":"Ando","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biomaterials.2017.06.021","article-title":"Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer","volume":"140","author":"Kinoshita","year":"2017","journal-title":"Biomaterials."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0125","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0378-4347(98)00566-0","article-title":"Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography","volume":"724","author":"Lee","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","article-title":"Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation","volume":"133","author":"Danhier","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.leu.2402464","article-title":"Developmental therapeutics program at the NCI: molecular target and drug discovery process","volume":"16","author":"Monga","year":"2002","journal-title":"Leukemia."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0140","unstructured":"ABRAXANE\u2122 for Injectable Suspension (Paclitaxel Protein-bound Particles for Injectable Suspension), the U.S. Food and Drug Administration, v12, 2005."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4251\/wjgo.v7.i11.285","article-title":"Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: intraperitoneal chemotherapy with taxanes","volume":"7","author":"Yamaguchi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10120-016-0662-9","article-title":"Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis","volume":"20","author":"Kobayashi","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00280-003-0680-2","article-title":"Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions","volume":"52","author":"Mohamed","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0160","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","article-title":"Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel","volume":"24","author":"Tsai","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0165","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1021\/acs.biomac.0c00107","article-title":"Human dermal fibroblast viability and adhesion on cellulose nanomaterial coatings: influence of surface characteristics","volume":"21","author":"Kummala","year":"2020","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1517\/14740338.6.5.609","article-title":"Paclitaxel: a review of adverse toxicities and novel delivery strategies","volume":"6","author":"Marupudi","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00002018-200023050-00005","article-title":"Risks and benefits of taxanes in breast and ovarian cancer","volume":"23","author":"Michaud","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0180","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"Van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(25)28988-1","article-title":"The route of absorption of intraperitoneally administered compounds","volume":"178","author":"Lukas","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.2600740902","article-title":"Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration","volume":"74","author":"Hlrano","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0195","first-page":"363","article-title":"Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel","volume":"9","author":"Chen","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0200","first-page":"3504","article-title":"Down-regulation of survivin enhances paclitaxel-induced Hela cell apoptosis","volume":"21","author":"Gu","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0205","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S1470-2045(13)70436-4","article-title":"Management of gastric cancer in Asia: resource-stratified guidelines","volume":"14","author":"Shen","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000334593","article-title":"Pancreatic cancer is not noble","volume":"4","author":"Lotze","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0215","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/or.2014.3210","article-title":"Comparative study of the antitumor activity of nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer","volume":"32","author":"Kinoshita","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2021.01.201_bb0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2019.1704945","article-title":"Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review","volume":"27","author":"Van de Sande","year":"2020","journal-title":"Drug Deliv."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302100249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302100249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:43:57Z","timestamp":1758876237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302100249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":46,"alternative-id":["S014181302100249X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.201","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX\/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}